Navigation Links
David Hsia, Ph.D. Joins Kinex Pharmaceuticals' Board of Directors
Date:9/15/2008

BUFFALO, N.Y., Sept. 15 /PRNewswire/ -- Kinex Pharmaceuticals announced that David Hsia, Ph.D. has been appointed to the Company's Board of Directors.

Dr. Hsia is a pharmaceutical veteran. He is a co-founder of Watson Pharmaceuticals, a publicly traded company listed in New York Stock Exchange (ticker: WPI). He was formerly Senior Vice President, Scientific Affairs of Watson Pharmaceuticals before his retirement. He has been involved in the development of various pharmaceutical formulations for over twenty years. Dr. Hsia received a Ph.D. in Industrial and Physical Pharmacy from Purdue University in 1975.

"Dr. Hsia is well known for his expertise in pharmaceutical development in our industry," commented Dr. Allen Barnett, Chief Executive Officer of Kinex Pharmaceuticals. "As the Company moves forward, we look forward to leveraging the full breadth of David's expertise as a Board member to assist us in developing our new drug candidates," Commented Dr. Johnson Lau, Executive Chairman of the Board.

"I am delighted to have a chance to work with the team at Kinex. The company's pipeline is very strong and I am glad to have this opportunity to assist to further advance their product pipeline," commented Dr. Hsia.

About Kinex Pharmaceuticals

Kinex is a drug discovery and development company that is focused on the use of its platform technology and compound libraries to identify and develop peptide-competitive kinase inhibitors. The Company's clinical compound KX2-391 is a selective Src kinase inhibitor that is currently in Phase 1 trials for oncology. Kinex's pipeline is focused on selective inhibitors for kinase targets that are important in oncology and inflammation and immunology. The Company is located in the New York State Center of Excellence in Bioinformatics and Life Sciences, on the Buffalo Niagara Medical Campus in Buffalo, New York.


'/>"/>
SOURCE Kinex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
2. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
3. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
4. Omeros Appoints David A. Mann to its Board of Directors
5. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
6. David Farhadi, M.D. to Join Alger as Vice President, Senior Analyst/Co-Portfolio Manager
7. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
8. David M. Stout Joins NanoBio Corporations Board of Directors
9. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
10. Abingworth Appoints David Mayer as Partner
11. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. ... DCVax® personalized immune therapies for operable and inoperable solid ... , Chief Technical Officer of NW Bio, will present ... 19, 2017, at the Hyatt Regency Hotel in ... will chair the session entitled "New Therapeutic Approaches – ...
(Date:1/19/2017)... , Jan. 18, 2017 BD (Becton, Dickinson and ... announced today that it will host a live webcast of its ... p.m. (ET). The webcast can be accessed from ... for replay through Tuesday, January 31, 2017. ... About BD BD is a ...
(Date:1/18/2017)... 2017 According to a new market research report "In ... Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global ... 739.9 Million by 2021 from USD 557.1 Million in 2016, growing at a ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017 ... applying mechanistic modeling to drug research and development, ... PhD, Co-Founder, President, and CEO of Applied BioMath, ... for Informatics and Modeling (BAGIM) Meeting on Thursday ... Cambridge , MA.   Dr. Burke,s ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
(Date:12/7/2016)... Avanade is helping Williams Martini Racing, one of ... biometric data in order to critically analyse every aspect ... against their rivals after their impressive, record-breaking pit stop ... with Williams during the 2016 season to capture and ... rate, temperature and peak acceleration) for key members of ...
Breaking Biology News(10 mins):